BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zoccarato M, Saddi MV, Serra G, Pelizza MF, Rosellini I, Peddone L, Ticca A, Giometto B, Zuliani L. Aquaporin-4 antibody neuromyelitis optica following anti-NMDA receptor encephalitis. J Neurol 2013;260:3185-7. [PMID: 24253480 DOI: 10.1007/s00415-013-7182-x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Apiraksattayakul N, Songwisit S, Owattanapanich W, Tisavipat N, Siritho S, Prayoonwiwat N, Rattanathamsakul N, Jitprapaikulsan J. AQP4-IgG-positive neuromyelitis optica spectrum disorder and temporally detected neoplasms: case report and systematic review. Multiple Sclerosis and Related Disorders 2022;68:104212. [DOI: 10.1016/j.msard.2022.104212] [Reference Citation Analysis]
2 Zhang S, Yang Y, Liu W, Li Z, Li J, Zhou D. Clinical Characteristics of Anti-N-Methyl-d-Aspartate Receptor Encephalitis Overlapping with Demyelinating Diseases: A Review. Front Immunol 2022;13:857443. [DOI: 10.3389/fimmu.2022.857443] [Reference Citation Analysis]
3 Zhang XY, An DM, Liu L. MOG antibody disease with ovarian teratoma: A case report and review of the literature. Journal of Neuroimmunology 2022. [DOI: 10.1016/j.jneuroim.2022.577858] [Reference Citation Analysis]
4 Chen X, Ren Y, Zhang Y, Lu W. Comparative study of AQP4 antibody-related diseases and MOG antibody-related diseases among the population in Hunan, China. Acta Neurol Belg 2021;121:1649-59. [PMID: 32737792 DOI: 10.1007/s13760-020-01455-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lohmann L, Klotz L, Wiendl H. [Neuromyelitis Optica Spectrum Disorders - Present Insights and Recent Developments]. Fortschr Neurol Psychiatr 2021;89:516-30. [PMID: 34666391 DOI: 10.1055/a-1556-7008] [Reference Citation Analysis]
6 Shahmohammadi S, Doosti R, Shahmohammadi A, Azimi A, Sahraian MA, Fattahi MR, Naser Moghadasi A. Neuromyelitis optica spectrum disorder (NMOSD) associated with cancer: A systematic review. Mult Scler Relat Disord 2021;56:103227. [PMID: 34536774 DOI: 10.1016/j.msard.2021.103227] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
7 Ikeguchi R, Shimizu Y, Shimomura A, Suzuki M, Shimoji K, Motohashi T, Yamamoto T, Shibata N, Kitagawa K. Paraneoplastic AQP4-IgG-Seropositive Neuromyelitis Optica Spectrum Disorder Associated With Teratoma: A Case Report and Literature Review. Neurol Neuroimmunol Neuroinflamm 2021;8:e1045. [PMID: 34285095 DOI: 10.1212/NXI.0000000000001045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Chahal K, Endeman T, Scapinello S, Sapieha M. Anti-N-methyl-D-aspartate receptor encephalitis presenting as atypical psychosis in multiple sclerosis: a case report. BMC Psychiatry 2021;21:347. [PMID: 34247615 DOI: 10.1186/s12888-021-03351-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Lohmann L, Klotz L, Wiendl H. Neuromyelitis-optica-Spektrum-Erkrankungen – alte und neue Entwicklungen. Neuroradiologie Scan 2021;11:111-126. [DOI: 10.1055/a-1372-9203] [Reference Citation Analysis]
10 Belova AN, Grygorieva VN, Rasteryaeva MV, Ruina EA, Belova EM, Solovieva VS, Boyko AN. Anti-NMDAR Encephalitis with Relapsing Optic Neuritis. Neurosci Behav Physi 2021;51:163-170. [DOI: 10.1007/s11055-021-01053-x] [Reference Citation Analysis]
11 Du L, Wang H, Zhou H, Chang H, Wei Y, Cong H, Xu W, Ma Y, Song T, Zhang X, Yin L. Anti-NMDA receptor encephalitis concomitant with myelin oligodendrocyte glycoprotein antibody diseases: A retrospective observational study. Medicine (Baltimore) 2020;99:e21238. [PMID: 32756102 DOI: 10.1097/MD.0000000000021238] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
12 Belova AN, Grygorieva VN, Rasteryaeva MV, Ruina EA, Belova EM, Solovieva VS, Boyko AN. [Anti-NMDAR encephalitis associated with relapsing optic neuritis]. Zh Nevrol Psikhiatr Im S S Korsakova 2020;120:105-13. [PMID: 32678556 DOI: 10.17116/jnevro2020120061105] [Reference Citation Analysis]
13 Bohm PE, Chen JJ, Bhatti TM, Eggenberger ER. Neuro-Ophthalmic Features of Autoimmune Encephalitides. Journal of Neuro-Ophthalmology 2020;40:385-97. [DOI: 10.1097/wno.0000000000001005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
14 Hung SC. Imaging of Neuromyelitis Optica Spectrum Disorders. Semin Ultrasound CT MR 2020;41:319-31. [PMID: 32448488 DOI: 10.1053/j.sult.2020.02.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Yoshimura M, Uehara T, Tanaka E, Okadome T, Yamaguchi T, Maeda Y, Isobe N, Matsushita T, Yamasaki R, Kira J. Double positivity for anti‐ N ‐methyl‐ d ‐aspartate receptor and anti‐aquaporin‐4 antibodies in a patient presenting with hypersomnolence, personality change, and reduced spontaneity. Clin Exp Neuroimmunol 2020;11:53-56. [DOI: 10.1111/cen3.12571] [Reference Citation Analysis]
16 Belova AN, Grygorieva VN, Rasteryaeva MV, Ruina EA, Belova EM, Solovieva VS, Boyko AN. [Anti-NMDAR encephalitis associated with relapsing optic neuritis: a case report and differential diagnosis]. Zh Nevrol Psikhiatr Im S S Korsakova 2019;119:137-46. [PMID: 31934999 DOI: 10.17116/jnevro201911910137] [Reference Citation Analysis]
17 Filippi M, Rocca MA. Neuromyelitis Optica Spectrum Disorders. White Matter Diseases 2020. [DOI: 10.1007/978-3-030-38621-4_3] [Reference Citation Analysis]
18 Seok JM, Oh HJ, Lee SC, Park MS. Limbic encephalitis-like presentation in neuromyelitis optica spectrum disorder: a case report. Acta Neurol Belg 2019;119:637-9. [PMID: 30835052 DOI: 10.1007/s13760-019-01114-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
19 Schulz DC, Pandey SK, Bursztyn LLCD. Optic Nerve Atrophy in N-methyl-D-aspartate (NMDA) Encephalitis. Can J Neurol Sci 2020;47:139-41. [PMID: 31724524 DOI: 10.1017/cjn.2019.325] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
20 Tao S, Zhang Y, Ye H, Guo D. AQP4-IgG-seropositive neuromyelitis optica spectrum disorder (NMOSD) coexisting with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: A case report and literature review. Mult Scler Relat Disord 2019;35:185-92. [PMID: 31398657 DOI: 10.1016/j.msard.2019.07.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
21 Alves Do Rego C, Collongues N. Neuromyelitis optica spectrum disorders: Features of aquaporin-4, myelin oligodendrocyte glycoprotein and double-seronegative-mediated subtypes. Rev Neurol (Paris) 2018;174:458-70. [PMID: 29685427 DOI: 10.1016/j.neurol.2018.02.084] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
22 Shahmohammadi S, Doosti R, Shahmohammadi A, Mohammadianinejad SE, Sahraian MA, Azimi AR, Harirchian MH, Asgari N, Naser Moghadasi A. Autoimmune diseases associated with Neuromyelitis Optica Spectrum Disorders: A literature review. Mult Scler Relat Disord 2019;27:350-63. [PMID: 30476871 DOI: 10.1016/j.msard.2018.11.008] [Cited by in Crossref: 62] [Cited by in F6Publishing: 50] [Article Influence: 15.5] [Reference Citation Analysis]
23 Dutra BG, da Rocha AJ, Nunes RH, Maia ACM Júnior. Neuromyelitis Optica Spectrum Disorders: Spectrum of MR Imaging Findings and Their Differential Diagnosis. Radiographics 2018;38:169-93. [PMID: 29320331 DOI: 10.1148/rg.2018170141] [Cited by in Crossref: 69] [Cited by in F6Publishing: 70] [Article Influence: 17.3] [Reference Citation Analysis]
24 Fan S, Xu Y, Ren H, Guan H, Feng F, Gao X, Ding D, Fang F, Shan G, Guan T, Zhang Y, Dai Y, Yao M, Peng B, Zhu Y, Cui L. Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis. Mult Scler Relat Disord 2018;20:144-52. [PMID: 29414288 DOI: 10.1016/j.msard.2018.01.007] [Cited by in Crossref: 62] [Cited by in F6Publishing: 52] [Article Influence: 15.5] [Reference Citation Analysis]
25 Lynch DR, Rattelle A, Dong YN, Roslin K, Gleichman AJ, Panzer JA. Anti-NMDA Receptor Encephalitis: Clinical Features and Basic Mechanisms. Adv Pharmacol 2018;82:235-60. [PMID: 29413523 DOI: 10.1016/bs.apha.2017.08.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 5.6] [Reference Citation Analysis]
26 Zabad RK, Stewart R, Healey KM. Pattern Recognition of the Multiple Sclerosis Syndrome. Brain Sci 2017;7:E138. [PMID: 29064441 DOI: 10.3390/brainsci7100138] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
27 Rosales D, Kister I. Common and Rare Manifestations of Neuromyelitis Optica Spectrum Disorder. Curr Allergy Asthma Rep 2016;16:42. [PMID: 27167974 DOI: 10.1007/s11882-016-0619-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
28 Ran Y, Wang L, Zhang F, Ao R, Dong Z, Yu S. Anti-NMDAR encephalitis followed by seropositive neuromyelitis optica spectrum disorder: A case report and literature review. Clinical Neurology and Neurosurgery 2017;155:75-82. [DOI: 10.1016/j.clineuro.2017.02.016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
29 Mugavin M, Mueller BH 2nd, Desai M, Golnik KC. Optic Neuropathy As the Initial Presenting Sign of N-methyl-d-aspartate (NMDA) Encephalitis. Neuroophthalmology 2017;41:90-3. [PMID: 28348631 DOI: 10.1080/01658107.2016.1262431] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
30 Qin K, Wu W, Huang Y, Xu D, Zhang L, Zheng B, Jiang M, Kou C, Gao J, Li W, Zhang J, Wang S, Luan Y, Yan C, Xu D, Zheng X. Anti-N-methyl-D-aspartate receptor(NMDAR) antibody encephalitis presents in atypical types and coexists with neuromyelitis optica spectrum disorder or neurosyphilis. BMC Neurol. 2017;17:1. [PMID: 28056870 DOI: 10.1186/s12883-016-0787-9] [Cited by in Crossref: 37] [Cited by in F6Publishing: 43] [Article Influence: 7.4] [Reference Citation Analysis]
31 Yokoyama K, Hori M, Yoshida A. Anti-myelin oligodendrocyte glycoprotein antibody neuritis optica following anti-NMDA receptor encephalitis. Pediatrics International 2016;58:953-4. [DOI: 10.1111/ped.13053] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
32 Cai G, He D, Chu L, Dai Q, Xu Z, Zhang Y. Paraneoplastic neuromyelitis optica spectrum disorders: three new cases and a review of the literature. Int J Neurosci 2016;126:660-8. [PMID: 26010208 DOI: 10.3109/00207454.2015.1054481] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
33 Wang RJ, Chen BD, Qi D. Anti-N-methyl-D-aspartate receptor encephalitis concomitant with multifocal subcortical white matter lesions on magnetic resonance imaging: a case report and review of the literature. BMC Neurol 2015;15:107. [PMID: 26152327 DOI: 10.1186/s12883-015-0366-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
34 Waschbisch A, Kallmünzer B, Schwab S, Gölitz P, Vincent A, Lee DH, Linker RA. Demyelinating disease and anti-N-methyl-D-aspartate receptor immunoglobulin G antibodies: a case report. BMC Res Notes 2014;7:948. [PMID: 25539977 DOI: 10.1186/1756-0500-7-948] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
35 Tanaka M, Kinoshita M. Congress report of the 2014 American Academy of Neurology annual meeting. Clin Exp Neuroimmunol 2014;5:391-399. [DOI: 10.1111/cen3.12141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
36 Irani SR, Gelfand JM, Al-Diwani A, Vincent A. Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms. Ann Neurol 2014;76:168-84. [PMID: 24930434 DOI: 10.1002/ana.24200] [Cited by in Crossref: 131] [Cited by in F6Publishing: 139] [Article Influence: 16.4] [Reference Citation Analysis]
37 Outteryck O, Baille G, Hodel J, Giroux M, Lacour A, Honnorat J, Zéphir H, Vermersch P. Extensive myelitis associated with anti-NMDA receptor antibodies. BMC Neurol 2013;13:211. [PMID: 24373538 DOI: 10.1186/1471-2377-13-211] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]